SCHEMBL981631

SCHEMBL981631

COCCOc1cccc(C2OC=CO2)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
MAPK1 P28482 2/20 0.40
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
HIF1A Q16665 1/20 0.40
TRPA1 O75762 4/20 0.38
SYK P43405 1/20 0.37
P2RX3 P56373 1/20 0.37
KDM4E B2RXH2 1/20 0.37
BRD4 O60885 1/20 0.36
CCL2 P13500 1/20 0.36
HTR2A P28223 1/20 0.36
GRM2 Q14416 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL767828 0.86 CYP3A4 (0.39) ALDH1A1TSHRSMN1; SMN2CYP2D6CYP2C19
SCHEMBL984529 0.86 KMT2A (0.46) ALDH1A1TSHRSMN1; SMN2CYP1A2CYP2C19
SCHEMBL984461 0.84 TSHR (0.46) TSHRSMN1; SMN2CYP1A2CYP2C19
SCHEMBL5346832 0.84 SMN1; SMN2 (0.39) ALDH1A1MAPK1TSHRSMN1; SMN2TP53
SCHEMBL5725738 0.83 SMN1; SMN2 (0.38) ALDH1A1TSHRSMN1; SMN2TP53CYP3A4
SCHEMBL984346 0.82 TP53 (0.49) ALDH1A1MAPK1TSHRSMN1; SMN2CYP1A2
SCHEMBL1276651 0.81 TSHR (0.41) ALDH1A1MAPK1TSHRSMN1; SMN2CYP1A2
SCHEMBL3078804 0.81 TSHR (0.40) ALDH1A1TSHRSMN1; SMN2TP53CYP3A4
SCHEMBL746723 0.80 HTR2C (0.49) ALDH1A1SMN1; SMN2CYP2D6CYP2C19CYP3A4
SCHEMBL7975035 0.78 ALDH1A1 (0.70) ALDH1A1TSHRSMN1; SMN2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8445501-B2 Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines TAKEDA GMBH (DE) 2013-05-21 US disclosed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed
EP-2247594-A1 PYRROLOPYRIMIDINECARBOXAMIDES Nycomed GmbH (DE) 2010-11-10 EP disclosed
WO-2009106531-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2009-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A ALDH1A1 924/4885MAPK1 2403/4885TSHR 3033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.